Log In
BCIQ
Print this Print this
 

CRB0089

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionHuman mAb targeting neurotrophic tyrosine kinase receptor 1 (TrkA; NTRK1)
Molecular Target Neurotrophic tyrosine kinase receptor 1 (TrkA) (NTRK1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat osteoarthritis (OA) pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today